Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06873178 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer

Study acronym: PCLM:CSSG
StatusUnknown
PhaseNot specified
Started2024-08-23
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 16, 2025 (before its estimated April 30, 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
Trial status changed: Active, Not Recruiting → Unknown
2025-04-13
Study Identification, Study Status v1
Trial statusActive, Not Recruiting→Unknown
Study title-4 characters
The Significance and Indications of SurgeryforSurgery for Synchronous Liver Metastases fromMetastatic Pancreatic Cancer
2025-03-06
Original filing
To explore the clinical characteristics of pancreatic cancer patients with liver metastases who can benefit from surgery, and to develop evaluation criteria for surgical indications, so as to provide basis for comprehensive treatment strategies for advanced pancreatic cancer patients.
Trial Details
NCT Number NCT06873178
Lead Sponsor China-Japan Friendship Hospital
Collaborators: Peking University First Hospital, Chongqing General Hospital, Tongji Hospital, Zhejiang Provincial People's Hospital
Conditions Pancreatic Cancer, Liver Metastases, Surgery, Adjuvant Therapy
Enrollment 50 participants
Start Date 2024-08-23
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-16